Skip to content
Highlighted coinsYour coin here?
  • Promote your project in this bar.
Ad

Analysis

Injective faces potential declines as futures open interest falls

Injective faces downward pressure as its price drops toward $7.42, accompanied by falling futures open interest and a taker buy-to-sell ratio of 0.96 indicating a slight advantage for sellers.

Injective faces potential declines as futures open interest falls

Key Takeaways

  • Injective (INJ) changes hands at approximately $7.42 on Thursday, extending its losses following a 5.7% drop during the prior session.
  • The futures taker buy-to-sell ratio rests at 0.96, with sell transactions making up 51.1% of overall taker activity, indicating a mild edge for sellers.
  • A breakdown beneath the $7.19 trendline support risks dragging INJ down toward $6.71 and $6.27, whereas a push past $8.35 could clear a path toward $9.41.

Injective (INJ) continues to face downward pressure on Thursday, lingering below $7.50 as sliding derivatives volume and persistent selling hamper short-term recovery hopes.

The digital asset hovers near $7.42 after giving up about 6% in Wednesday’s trading, reflecting a lack of trader confidence in an immediate turnaround.

Data from CoinGlass points to a continuous drop in futures Open Interest beginning in mid-October, while market sell orders outpace aggressive buying.

Injective futures OI falls as traders reduce exposure

Market participation within Injective’s derivatives sector has dropped significantly over recent weeks.

CoinGlass reports that INJ futures Open Interest decreased by 4% over a 24-hour window, settling at $140.77 million.

A persistent decline typically signals that traders are trimming their exposures, pointing to diminished speculative enthusiasm or broader market uncertainty.

CoinGlass figures further demonstrate that sellers maintain a slight advantage in Injective’s futures arena.

The INJ taker buy-to-sell ratio registers at 0.96, signifying that aggressive sell orders outpace aggressive buy orders.

A ratio sitting under 1 usually implies that market-order traders are more inclined to offload assets into current bids than acquire them from existing asks.

Injective technical outlook: INJ tests the crucial $7.19 trendline support

Injective’s daily chart reveals a mixed technical picture, with the cryptocurrency sandwiched between a key moving average and an ascending support trendline.

During Thursday’s trading session, INJ trades close to $7.42, just under its 50-day Exponential Moving Average of approximately $7.55.

This inability to reclaim the moving average indicates that buyers have yet to take charge of the near-term trend.

Even so, Injective stays positioned above an upward support trendline near $7.19. The 200-day EMA, sitting close to $6.27, also remains beneath the current market price.

Remaining above this longer-term moving average implies the broader technical framework has not degraded as heavily as the recent price decline might suggest.

Momentum indicators, however, are beginning to soften. The Moving Average Convergence Divergence (MACD) has slipped below its signal line, signaling that bullish momentum is fading.

Simultaneously, the Relative Strength Index (RSI) registers around 44, resting just beneath the neutral 50 mark.

This points to growing influence from sellers, though the asset has not yet slipped into oversold territory.

The ascending trendline near $7.19 serves as Injective’s initial critical downside support.

INJ/USD Daily Chart

A confirmed drop below this line would weaken the present technical structure and imply stronger control by sellers.

Should INJ break decisively past the trendline, the next notable support sits at $6.71. Failing to hold $6.71 would leave Injective vulnerable to another vital support zone around $6.27.

Despite current weakness, Injective could stage another recovery if buyers successfully defend the $7.19 support trendline.

The initial hurdle is located at the 50-day EMA near $7.55. A sustained rebound past this threshold would signal recovering buying momentum and potentially prompt traders to eye higher resistances.

The subsequent major barrier is situated at $8.35, a horizontal resistance level that checked Injective’s advances over the preceding week.

A decisive daily close above $8.35 would reinforce the bullish outlook and potentially clear the way for a recovery toward $9.41.

Frequently Asked Questions

What is the current price of Injective (INJ)?

Injective (INJ) is trading around $7.42 on Thursday, extending losses after a 5.7% decline in the previous session.

What does the futures taker buy-to-sell ratio indicate for INJ?

The futures taker buy-to-sell ratio is at 0.96, with sell orders making up 51.1% of taker activity, signaling that sellers hold a slight advantage.

What are the key support and resistance levels to watch for Injective?

The immediate downside support is near the $7.19 trendline, with subsequent supports at $6.71 and $6.27. On the upside, resistance levels are found at the 50-day EMA near $7.55, followed by horizontal resistance at $8.35 and a potential target of $9.41.

What is happening to Injective’s futures Open Interest?

According to CoinGlass data, INJ futures Open Interest dropped by 4% over a 24-hour period to reach $140.77 million, reflecting a steady reduction in derivatives exposure since mid-October.

Explained in this article

  • Cryptocurrency

    A digital asset recorded on a blockchain and controlled by private keys. Full definition →

  • Bull Market

    A sustained period of rising prices and optimism. Full definition →

Leave a Reply

Your email address will not be published. Required fields are marked *